Bhanwra, S. and Ahluwalia, K. (2016) “Empagliflozin: the latest SGLT2 inhibitor on the block”, International Journal of Basic & Clinical Pharmacology, 5(2), pp. 539–542. doi: 10.18203/2319-2003.ijbcp20160777.